CUSIP: 590328100
Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
79,827,711
-
Share change
-
-10,918,188
-
Total reported value
-
$245,866,098
-
Put/Call ratio
-
203%
-
Price per share
-
$3.08
-
Number of holders
-
111
-
Value change
-
-$59,162,459
-
Number of buys
-
44
-
Number of sells
-
65
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM (MACK) as of Q1 2017
As of 31 Mar 2017,
MERRIMACK PHARMACEUTICALS IN - COM (MACK) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,827,711 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, TIAA CREF INVESTMENT MANAGEMENT LLC, FRANKLIN RESOURCES INC, TEACHERS ADVISORS, LLC, NORTHERN TRUST CORP, NORGES BANK, and GOLDMAN SACHS GROUP INC.
This page lists
111
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.